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GENERAL COMMENTS
This manuscript is a protocol for an antenatal lifestyle programme to improve maternal and infant health outcomes for normal weight women. The authors have lots of experience in this area so it is not surprising that appears to be a well designed intervention and study. However, I do feel that a few edits are needed to this manuscript before publication just to clarify a few details to the reader: 1. The title mentions 'optimising gestational weight gain' and the introduction focuses on GWG but the aim stated at the end of the introduction does not mention weight gain and instead focuses on the role of exercise and dietary behaviours on maternal and fetal outcomes -there seems to be a paragraph missing linking this all together. Likewise, in the study aims, GWG is mentioned in the 3rd secondary aim -should this be a primary aim or should the wording of the title and focus of the introduction change slightly to be on infant weight instead?
2. The 'strengths and limitations' states that outcomes are only being measured until birth and hospital discharge but the method section mentions measuring outcome measures six-month postnatal -this seems to be an inconsistency.
3. The BMJ guidelines state that protocols for studies can be ongoing so this meets the guidelines but as recruitment started a long time (three years) and considering you aim to recruit a sample of 624 women of 'normal weight' with few restrictions, I wonder if you need to give us some preliminary data or an update on recruitment to the study.
4.
A little bit more information about the intervention content would be good e.g., how is it based on what you learnt in the LIMIT trial? How will partners be included? Will this be a rolling programme or run with a set number of women each time?
5. What stages of changes models are you proposing to use? You reference a health psychology text book which lists many so this needs clarity with a model / constructs named and referenced correctly. The theoretical underpinnings of behaviour change interventions is very important so needs more detail.
6. The terms physical activity and exercise are used interchangeably so it is hard to know what is being covered with participants in terms of this detail.
7. What is the logic of stratification based on parity? This needs some justification.
8. How can you be sure that 'standard care' receives no dietary intake and physical activity advice in pregnancy? It might be better to reword this to 'a minimal amount' instead.
9. Preterm birth before 37 weeks gestation -I wonder if you need to break this down further.
10. Does your sample size take into account drop out?
VERSION 1 -AUTHOR RESPONSE
Reviewer 1:
1. The abstract should state this is a randomised controlled trial not randomised trial?
Response: Thank you for this suggestion, we have added the word 'controlled'
2.The term healthy weight should be used not normal weight.
Response: We cannot find any instances where we have prefaced the word 'weight' with 'normal'. We have used the term 'normal BMI' throughout, this descriptor for BMI of 18.5-24.9 kg/m2 is defined by the World Health Organisation.
3. Justification for why infant weight has been (chosen) as the primary outcome is required.
Response: High infant birth weight above 4.0kg is a clinically meaningful outcome and independently associated with excess gestational weight gain, abnormal maternal glucose tolerance or inflammation. High infant birth weight is also independently associated with an increased risk of pre-school obesity,1-3 increasing by a factor of 1.08 (95% CI 1.03-1.14) per kilogram of GWG. 4. Are there any plans to assess intervention delivery and fidelity?
Response: Women participating in the intervention group will have two appointments with the study dietitian, one appointment with a trained research assistant and three phone calls from a trained research assistant. The content of all of the intervention sessions is guided by the written study materials which include prompts and checklists for key points. Goals set by participants are recorded and reviewed at the next session. There will be only one study dietitian who will conduct all of the dietitian lead sessions and train and supervise the research assistants, thereby ensuring consistency and fidelity in the delivery of the intervention.
5. The manuscript state that where possible care providers, outcome assessors and data analysts will be blinded to treatment allocation. Since it is possible to have binding for all these it is not clear why this can't be confirmed rather than when possible?
Response: Whilst every effort will be made to maintain blinding of care providers, it is not possible to guarantee that participants will not discuss their participation in the trial. Similarly, care providers may note trial participation a participant's case notes where it may be viewed by outcome assessors. Periodic education sessions for care providers will be offered.
The statistician will remain blinded to treatment group until the data have been cleaned and analysed.
6. The intervention is not well justified. Why are participants being given 3 phone calls? Why not 2 or 4 or 6 for example? Is there any pilot work to support the selection of this intervention?
Response: The intervention is based on The Australian Guide to Healthy Eating and our experience with previous pregnancy lifestyle intervention trials where women successfully improved their diet quality and increased their level of incidental physical activity. 1,2
We have specified women will receive 3 phone calls as well as 3 face to face intervention sessions, 2 of which will be with the trial dietitian. This equates to approximately 6 intervention contacts over 19 -22 weeks, or one contact every 3-4 weeks. This is consistent with dietary intervention recommendations and this frequency was well received in our previous lifestyle intervention trials.
The intervention is intentionally designed to be achievable and affordable within the current Australian health care system. 8. It is stated that participants will self-monitor their progress-how exactly are participants doing this?
Response:Women will be counseled and assisted to identify their own achievable goals during the intervention, to identify potential barriers to behavior change, and will be encouraged to self-monitor their progress in the achievement of their goals (for example achieving their desired changes to dietary or physical activity behaviours).
9. Will intervention contamination be assessed in this trial? Given the nature of the trial there is medium risk of intervention contamination?
Response:There is some risk that women in the control group and the intervention group may seek their own dietary and physical activity advice outside of the trial. The intervention in our trial is in addition to information that can be independently sourc ed by any participant in the trial.
10. It is stated that weight will be recorded a trial entry -who is measuring weight and will this be blinded and objectively measured? Will weight be objectively recorded at follow up or is self-reported weight being used?
Response: Women attending the antenatal clinic for their first antenatal visit will be approached by trained research assistants who will ask the women if they consent to being screened for eligibility for the OPTIMISE Trial by having their height and weight measured and BMI calculated. The digital scales and stadiometer are calibrated and maintained by the antenatal clinic staff. The weight recorded at this visit prior to enrolling in the study is used as the trial entry weight.
Weight at 36 weeks will again be recorded by trained research assistants at the time of the 36 week ultrasound appointment. The woman's allocated treatment group is not recorded on the data sheet used at this appointment. Weight is recorded using digital scales, and correc ted to one decimal place.
11. It is not clear why the lead investigator will have access to the data? Data should be kept in a secure database where researchers cannot access. It's also not clear why and for what reasons the trial manager and statistician will have access to the data while the trial is ongoing?
Response: The lead investigator, trial manager and statistician will have access to the blinded data while the trial is ongoing for the purpose of data management and cleaning. The lead investigator and trial manager will oversee data collection. The statistician will review blinded data for cleaning and generate queries on outlying data.
12. The authors should check they have reported the methods is line with CONSORT.
Response: The authors have reported the trial protocol in line with the SPIRIT Checklist (Standard Protocol Items: Recommended for Reporting Intervention Trials) which was submitted with the manuscript. The authors will adhere to CONSORT when reporting the findings of this trial.
Reviewer: 2
1. The title mentions 'optimising gestational weight gain' and the introduction focuses on GWG but the aim stated at the end of the introduction does not mention weight gain and instead focuses on the role of exercise and dietary behaviours on maternal and fetal outcomes -there seems to be a paragraph missing linking this all together. Likewise, in the study aims, GWG is mentioned in the 3rd secondary aim -should this be a primary aim or should the wording of the title and focus of the introduction change slightly to be on infant weight instead?
Response: High infant birth weight above 4.0kg is a clinically meaningful outcome and independently associated with excess gestational weight gain, abnormal maternal glucose tolerance or inflammation. High infant birth weight is also independently associated with an increased risk of pre-school obesity,1-3 increasing by a factor of 1.08 (95% CI 1.03-1.14) per kilogram of GWG.
